| Q37504484 | A Critical, Nonlinear Threshold Dictates Bacterial Invasion and Initial Kinetics During Influenza |
| Q92456759 | A review of the cost-effectiveness of adult influenza vaccination and other preventive services |
| Q62899255 | Accounting for Healthcare-Seeking Behaviours and Testing Practices in Real-Time Influenza Forecasts |
| Q92720914 | Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessment |
| Q55085613 | Age- and risk-related appropriateness of the use of available influenza vaccines in the Italian elderly population is advantageous: results from a budget impact analysis. |
| Q90484018 | Age-Related Pathology Associated with H1N1 A/California/07/2009 Influenza Virus Infection |
| Q91941716 | Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females |
| Q91646601 | Age-related immunogenicity and reactogenicity of live oral cholera vaccine CVD 103-HgR in a randomized, controlled clinical trial |
| Q57469672 | An evaluation and update of methods for estimating the number of influenza cases averted by vaccination in the United States |
| Q49989801 | Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness |
| Q91863064 | Applying infectious disease forecasting to public health: a path forward using influenza forecasting examples |
| Q56536622 | Automated Real-Time Collection of Pathogen-Specific Diagnostic Data: Syndromic Infectious Disease Epidemiology |
| Q26749036 | Best practice in the prevention and management of paediatric respiratory syncytial virus infection |
| Q47305526 | Burden of influenza, respiratory syncytial virus, and other respiratory viruses and the completeness of respiratory viral identification among respiratory inpatients, Canada, 2003-2014. |
| Q93147298 | Burden of influenza-associated respiratory hospitalizations in the Americas, 2010-2015 |
| Q39530697 | Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010-2011. |
| Q89543091 | Characteristics of hospitalizations with an influenza diagnosis, France, 2012-2013 to 2016-2017 influenza seasons |
| Q92260186 | Clinical characteristics and outcomes during a severe influenza season in China during 2017-2018 |
| Q47105013 | Cohort profile: the China Ageing REespiratory infections Study (CARES), a prospective cohort study in older adults in Eastern China |
| Q50041766 | Comparison between influenza coded primary care consultations and national influenza incidence obtained by the General Practitioners Sentinel Network in Portugal from 2012 to 2017. |
| Q47552950 | Comparison of influenza vaccine effectiveness in preventing outpatient and inpatient influenza cases in older adults, northern Spain, 2010/11 to 2015/16. |
| Q92667355 | Comparison of the ID Now Influenza A & B 2, Cobas Influenza A/B, and Xpert Xpress Flu Point-of-Care Nucleic Acid Amplification Tests for Influenza A/B Virus Detection in Children |
| Q57093891 | Contemporary management of severe influenza disease in the intensive care unit |
| Q48504278 | Cost-effectiveness analysis of different seasonal influenza vaccines in the elderly Italian population |
| Q90016287 | Detection and Characterization of Influenza B Virus With Reduced Neuraminidase Susceptibility in a Stem Cell Transplant Recipient |
| Q30398276 | Developing a system to estimate the severity of influenza infection in England: findings from a hospital-based surveillance system between 2010/2011 and 2014/2015. |
| Q56770773 | Development and evaluation of a rapid nucleic acid amplification method to detect influenza A and B viruses in human respiratory specimens |
| Q101038516 | Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China |
| Q55220726 | Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014. |
| Q64136630 | Does influenza vaccination status change physician ordering patterns for respiratory viral panels? Inspection for selection bias |
| Q35898797 | Economic Impact of a New Rapid PCR Assay for Detecting Influenza Virus in an Emergency Department and Hospitalized Patients |
| Q35997535 | Effect of Culture-Independent Diagnostic Tests on Future Emerging Infections Program Surveillance |
| Q64130978 | Effects of Influenza Vaccination in the United States during the 2017-2018 Influenza Season |
| Q92916900 | Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study |
| Q47243597 | Epidemic forecasts as a tool for public health: interpretation and (re)calibration |
| Q52627557 | Epidemiological Studies to Support the Development of Next Generation Influenza Vaccines. |
| Q45325973 | Epidemiology and burden of influenza in the U.S. Department of Veterans Affairs |
| Q92202554 | Estimated Burden of Community-Onset Respiratory Syncytial Virus-Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014-15 |
| Q30400623 | Estimating Direct and Indirect Protective Effect of Influenza Vaccination in the United States |
| Q47102492 | Estimating disease burden of a potential A(H7N9) pandemic influenza outbreak in the United States |
| Q92123438 | Estimating the Incidence of Influenza at the State Level - Utah, 2016-17 and 2017-18 Influenza Seasons |
| Q55426279 | Estimating the Risk of Influenza-Like Illness Transmission Through Social Contacts: Web-Based Participatory Cohort Study. |
| Q49989809 | Estimating the burden of influenza-associated hospitalizations and deaths in Chile during 2012-2014. |
| Q41928075 | Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010-2016. |
| Q92801965 | Estimation of influenza and respiratory syncytial virus hospitalizations using sentinel surveillance data-La Paz, Bolivia. 2012-2017 |
| Q54262215 | Evaluating oseltamivir prescriptions in Centers for Medicare and Medicaid Services medical claims records as an indicator of seasonal influenza in the United States. |
| Q57545973 | Evaluation of mechanistic and statistical methods in forecasting influenza-like illness |
| Q29248093 | Evaluation of the point-of-care Becton Dickinson Veritor™ Rapid influenza diagnostic test in Kenya, 2013–2014 |
| Q89510678 | Exploring Influenza Vaccine Uptake and Its Determinants among University Students: A Cross-Sectional Study |
| Q92296564 | Factors associated with perceptions of influenza vaccine safety and effectiveness among adults, United States, 2017-2018 |
| Q38831972 | Foot-and-Mouth Disease Impact on Smallholders - What Do We Know, What Don't We Know and How Can We Find Out More? |
| Q96155819 | Frailty Is Associated With Increased Hemagglutination-Inhibition Titers in a 4-Year Randomized Trial Comparing Standard- and High-Dose Influenza Vaccination |
| Q99403393 | Health Research in JFEI Over a Decade: 2009-2019 |
| Q38662482 | Heterogeneity in Estimates of the Impact of Influenza on Population Mortality: A Systematic Review. |
| Q54263414 | Heterogeneous estimates of influenza virus types A and B in the elderly: Results of a meta-regression analysis. |
| Q55517635 | Higher mortality and hospital charges in patients with cirrhosis and acute respiratory illness: a population-based study. |
| Q58580913 | Hospitalization following Outpatient Medical Care for Influenza: US Influenza Vaccine Effectiveness Network, 2011-12-2015-16 |
| Q57164156 | Host-pathogen kinetics during influenza infection and coinfection: insights from predictive modeling |
| Q57232542 | Host-pathogen kinetics during influenza infection and coinfection: insights from predictive modeling |
| Q35914564 | Immunogenicity and Safety of Influenza Vaccination in Systemic Lupus Erythematosus Patients Compared with Healthy Controls: A Meta-Analysis |
| Q92188185 | Impact of a PCR point of care test for influenza A/B on an acute medical unit in a large UK teaching hospital: results of an observational, pre and post intervention study |
| Q47128858 | Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains |
| Q104734619 | Impacts of free vaccination policy and associated factors on influenza vaccination behavior of the elderly in China: A quasi-experimental study |
| Q92663029 | Improved forecasts of influenza-associated hospitalization rates with Google Search Trends |
| Q35997430 | Improving Accuracy of Influenza-Associated Hospitalization Rate Estimates |
| Q51339385 | Increasing Influenza Immunization Rates Among Retail Employees: An Evidence-Based Approach. |
| Q47720310 | Influenza Antiviral Prescribing for Outpatients with an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications during Five Influenza Seasons-United States, 2011-2016. |
| Q90108100 | Influenza B virus infections in Western Saxony, Germany in three consecutive seasons between 2015 and 2018: Analysis of molecular and clinical features |
| Q89880122 | Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA |
| Q30397977 | Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement |
| Q58110187 | Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017 |
| Q49987926 | Influenza Vaccines for Older Persons: Progress and Pitfalls |
| Q102053130 | Influenza vaccination among infection control teams: A EUCIC survey prior to COVID-19 pandemic |
| Q40134515 | Influenza vaccination in the elderly. |
| Q38774410 | Influenza vaccination modifies disease severity among community-dwelling adults hospitalized with influenza |
| Q54277492 | Influenza vaccine effectiveness in older adults compared with younger adults over five seasons. |
| Q64936560 | Influenza virus-related critical illness: prevention, diagnosis, treatment. |
| Q55367968 | Influenza virus: 16 years' experience of clinical epidemiologic patterns and associated infection factors in hospitalized children in Argentina. |
| Q63627692 | Local-Level Adult Influenza and Pneumococcal Vaccination Disparities: Chicago, Illinois, 2015-2016 |
| Q53689522 | Mapping of the US Domestic Influenza Virologic Surveillance Landscape. |
| Q47305431 | National burden of hospitalized and non-hospitalized influenza-associated severe acute respiratory illness in Kenya, 2012-2014. |
| Q46659780 | No association between influenza vaccination during pregnancy and adverse birth outcomes |
| Q56342276 | Overview of three influenza seasons in Georgia, 2014-2017 |
| Q56888501 | Patterns of seasonal influenza activity in U.S. core based statistical areas, described using prescriptions of oseltamivir in Medicare claims data |
| Q89684325 | Personal and social patterns predict influenza vaccination decision |
| Q42051056 | Prevention and control of influenza in children during the 2016-2017 seasonal epidemic |
| Q56999527 | Progress in Vaccine-Preventable and Respiratory Infectious Diseases-First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006-2015 |
| Q103002020 | Protective effect of influenza vaccination on cardiovascular diseases: a systematic review and meta-analysis |
| Q37733491 | Quantifying the therapeutic requirements and potential for combination therapy to prevent bacterial coinfection during influenza. |
| Q31030277 | RSV vaccine use--the missing data. |
| Q89125836 | Receipt of other routinely recommended vaccines relative to receipt of seasonal influenza vaccines: Trends from medicare administrative data, 2013-2015 |
| Q57169187 | Recent trends in life expectancy across high income countries: retrospective observational study |
| Q38388812 | Respiratory Viral Testing and Influenza Antiviral Prescriptions During Hospitalization for Acute Respiratory Illnesses |
| Q36754078 | Safety and Upper Respiratory Pharmacokinetics of the Hemagglutinin Stalk-Binding Antibody VIS410 Support Treatment and Prophylaxis Based on Population Modeling of Seasonal Influenza A Outbreaks |
| Q64255142 | Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study |
| Q90161186 | Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial |
| Q47219641 | School-Based Influenza Vaccination: Health and Economic Impact of Maine's 2009 Influenza Vaccination Program |
| Q90128064 | Seasonal influenza vaccination among primary health care workers in Southwestern Saudi Arabia |
| Q93160589 | Severity and outcomes of influenza-related pneumonia in type A and B strains in China, 2013-2019 |
| Q42629986 | Soloxolone methyl inhibits influenza virus replication and reduces virus-induced lung inflammation |
| Q91529544 | Structural basis for influenza virus NS1 protein block of mRNA nuclear export |
| Q38735773 | Surges of advanced medical support associated with influenza outbreaks |
| Q52329587 | Survival of the Enveloped Virus Phi6 in Droplets as a Function of Relative Humidity, Absolute Humidity, and Temperature. |
| Q47885843 | Systematic Assessment of Multiple Routine and Near-Real Time Indicators to Classify the Severity of Influenza Seasons and Pandemics in the United States, 2003-04 Through 2015-2016. |
| Q90195655 | Testosterone treatment of aged male mice improves some but not all aspects of age-associated increases in influenza severity |
| Q90379384 | The Ancestral Environment Shapes Antiviral CD8+ T cell Responses across Generations |
| Q36847186 | The Molecular Epidemiology and Evolutionary Dynamics of Influenza B Virus in Two Italian Regions during 2010-2015: The Experience of Sicily and Liguria |
| Q39117827 | The Role of Nucleotide-Binding Oligomerization Domain-Like Receptors in Pulmonary Infection. |
| Q30378144 | The US Influenza Hospitalization Surveillance Network |
| Q47576940 | The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza |
| Q54969920 | The burden of acute respiratory infections in Ecuador 2011-2015. |
| Q59354030 | The burden of influenza-associated respiratory hospitalizations in Bhutan, 2015-2016 |
| Q37011565 | The impact of influenza virus B in Italy: myth or reality? |
| Q57796868 | The incidence of symptomatic infection with influenza virus in the Netherlands 2011/2012 through 2016/2017, estimated using Bayesian evidence synthesis |
| Q59360903 | The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4 T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathway |
| Q47690334 | The seasonal incidence of symptomatic influenza in the United States |
| Q38799509 | The success of microneedle-mediated vaccine delivery into skin. |
| Q40122593 | Trends of influenza B during the 2010-2016 seasons in 2 regions of north and south Italy: The impact of the vaccine mismatch on influenza immunisation strategy. |
| Q37203832 | Two Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Studies To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza A Virus Monoclonal Antibody, MHAA4549A, in Healthy Volunteers |
| Q93160134 | Underdetection of laboratory-confirmed influenza-associated hospital admissions among infants: a multicentre, prospective study |
| Q49907349 | Using a hospital admission survey to estimate the burden of influenza-associated severe acute respiratory infection in one province of Cambodia-methods used and lessons learned. |
| Q57094027 | Utility of state-level influenza disease burden and severity estimates to investigate an apparent increase in reported severe cases of influenza A(H1N1) pdm09 - Arizona, 2015-2016 |
| Q39118400 | Viral Pneumonia and Acute Respiratory Distress Syndrome |
| Q36123109 | Viral deep sequencing needs an adaptive approach: IRMA, the iterative refinement meta-assembler |
| Q92379108 | What can urban mobility data reveal about the spatial distribution of infection in a single city? |